Wolverine Asset Management’s Novartis NVS Stock Holding History

Wolverine Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-31,360	Closed	-$2.41M	–	1621
2018 Q4	$2.41M	Sell	31,360 -46,760	-60%	-$3.64M	0.03%	491
2018 Q3	$6.03M	Buy	+78,120	New	+$5.78M	0.07%	276
2013 Q3	–	Sell	-16	Closed	-$2K	–	2817
2013 Q2	$2K	Buy	+16	New	+$1.04K	﹤0.01%	2502

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wolverine Asset Management's NVS Position: Q1 2019 in Review

Wolverine Asset Management sold out of Novartis (NVS) in Q1 2019, closing a stake of 9,345 shares — an estimated $718K sold.

Wolverine Asset Management first reported a position in NVS in Q1 2014 and held it in 5 quarters. The position peaked at $1.17M in Q3 2018. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

Wolverine Asset Management reported no remaining Novartis position as of Q1 2019 after selling out during the quarter.
Wolverine Asset Management sold 9,345 Novartis shares in Q1 2019, an estimated $718K.
Wolverine Asset Management first reported a position in Novartis in Q1 2014 and held it in 5 quarters.
Wolverine Asset Management's Novartis position peaked at $1.17M in Q3 2018.
1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on Wolverine Asset Management's 13F filing for Q1 2019, filed 15 May 2019.